Peregrine Asset Advisers, Inc.
Position in CTMX — CytomX Therapeutics, Inc.
CIK 1535227
Portland, OR
Position in CTMX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$38,250
-$9,690 QoQ
Shares Held
10,200
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#156
of 178 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in CTMX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Peregrine Asset Advisers, Inc. holds $789,611 across 5 Biotechnology names. CTMX ranks #4 (4.8% of the industry book) .
All Filings in CTMX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $38,250 | 10,200 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $47,940 | 10,200 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $42,600 | 10,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $31,900 | 10,000 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $22,700 | 10,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $6,360 | 10,000 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $10,300 | 10,000 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $11,800 | 10,000 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||